Emotional and social support for patients with retinitis pigmentosa could reduce the incidence of depressive disorder in this ...

Binod Dhakal, MD, associate professor, division of hematology and oncology, Medical College of Wisconsin and lead ...

Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative ...

Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective ...

The pharmacist is a critical member of the care team to help manage patients on treatment and contain costs of cancer care, said Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy, ...

After a small number of practices joined the Enhancing Oncology Model (EOM) in 2023, CMS has made some changes and opened the model back up for new practices to join.

Follow-up in men living with HIV who have sex with men should be performed to assess quality of life due to sexual function.

Out-of-pocket costs for biosimilars and generics are still high for patients despite these drugs leading to estimated savings ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

HDP-101, a novel antibody-drug conjugate, targets BCMA with a synthetic amanitin payload that causes tumor cell death.

On September 19, the FDA handed down its third amivantamab (Rybrevant; Johnson & Johnson) approval for 2024 in non–small cell lung cancer (NSCLC), giving the third-generation tyrosine kinase inhibitor ...

Panelists discuss how small cell lung cancer (SCLC) differs from non–small cell lung cancer in terms of staging, epidemiology ...